PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1490160
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1490160
The flow cytometry market is estimated to be valued at USD 7.52 Bn in 2024 and is expected to reach USD 15.39 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 10.8% from 2024 to 2031.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2024: | US$ 7.52 Bn |
Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
Forecast Period 2024 to 2031 CAGR: | 10.80% | 2031 Value Projection: | US$ 15.39 Bn |
The global flow cytometry market has been witnessing steady growth over the past few years due to the increasing applications of flow cytometry in research, clinical diagnostics, and treatment monitoring. Flow cytometry is a powerful laser-based technology used for analyzing the physiometric and biochemical characteristics of cells/particles as they flow in a fluid stream through a beam of light. Through staining with fluorescent probes and analysis on the basis of light scattering and fluorescence emission, flow cytometry allows examining the physical and chemical characteristics of cells and particles on a single-cell basis. Advancements in flow cytometry instruments, reagents, and software have enabled analyzing complex multicolor applications with high speed and accuracy. The growing proteomics and stem cell research along with increasing focus on personalized medicine are some of the key factors driving the demand for flow cytometry worldwide.
The global flow cytometry market is driven by factors such as increasing research activity in the fields of immunology and hematology, growing stem cell research funding, rising prevalence of HIV/AIDS and cancer worldwide, and technological advancements in flow cytometry instruments. However, high cost of flow cytometry products is a major restraint for the market. Meanwhile, emerging markets such as Asia Pacific and Latin America provide significant growth opportunities for market players. Growing focus on personalized medicine approaches also presents opportunity for use of flow cytometry in companion diagnostics. Adoption of fluorescence-activated cell sorting (FACS) for biomanufacturing and drug discovery is another key trend expected to propel the market growth during the forecast period.
Detailed Segmentation-